Outcome measures for development of new therapies in cystic fibrosis: are we making progress and what are the next steps?
作者信息
Ramsey Bonnie W
机构信息
Department of Pediatrics, University of Washington, Seattle, WA 98105-0371, USA.
出版信息
Proc Am Thorac Soc. 2007 Aug 1;4(4):367-9. doi: 10.1513/pats.200703-038BR.
Abstract
摘要
相似文献
1
Outcome measures for development of new therapies in cystic fibrosis: are we making progress and what are the next steps?
Proc Am Thorac Soc. 2007 Aug 1;4(4):367-9. doi: 10.1513/pats.200703-038BR.
2
Mucociliary clearance as an outcome measure for cystic fibrosis clinical research.
Proc Am Thorac Soc. 2007 Aug 1;4(4):399-405. doi: 10.1513/pats.200703-042BR.
3
Biomarkers for cystic fibrosis: are we progressing?
Am J Respir Crit Care Med. 2007 Apr 15;175(8):750-1. doi: 10.1164/rccm.200702-226ED.
4
Clinical trials in cystic fibrosis.
J Cyst Fibros. 2007 Apr;6(2):85-99. doi: 10.1016/j.jcf.2007.02.001.
5
The Cystic Fibrosis Foundation Patient Registry as a tool for use in quality improvement.
BMJ Qual Saf. 2014 Apr;23 Suppl 1:i9-14. doi: 10.1136/bmjqs-2013-002378. Epub 2014 Jan 17.
6
In celebration of expectoration: induced sputum indices as outcome measures in cystic fibrosis.
Am J Respir Crit Care Med. 2003 Dec 15;168(12):1412-3. doi: 10.1164/rccm.2310001.
7
Cystic fibrosis papers of the year 2012.
Paediatr Respir Rev. 2013 May;14 Suppl 1:28-30. doi: 10.1016/j.prrv.2013.02.006. Epub 2013 Feb 26.
8
Evaluating the evidence for airway-clearance therapy in cystic fibrosis.
Respir Care. 2009 Apr;54(4):458-60.
9
New therapies for cystic fibrosis.
J La State Med Soc. 1998 Dec;150(12):629-37.
10
A new model for cystic fibrosis management: control concept.
Pneumologia. 2011 Jul-Sep;60(3):150-4.
引用本文的文献
1
In vivo readout of CFTR function: ratiometric measurement of CFTR-dependent secretion by individual, identifiable human sweat glands.
PLoS One. 2013 Oct 24;8(10):e77114. doi: 10.1371/journal.pone.0077114. eCollection 2013.
2
Pediatric hospital medicine and children with medical complexity: past, present, and future.
Curr Probl Pediatr Adolesc Health Care. 2012 May;42(5):113-9. doi: 10.1016/j.cppeds.2012.01.002.
3
Protein biomarkers in cystic fibrosis research: where next?
Genome Med. 2010 Dec 16;2(12):88. doi: 10.1186/gm209.
4
Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy.
J Cyst Fibros. 2010 Jan;9(1):1-16. doi: 10.1016/j.jcf.2009.09.003. Epub 2009 Oct 14.
5
Potential role of high-mobility group box 1 in cystic fibrosis airway disease.
Am J Respir Crit Care Med. 2008 Oct 15;178(8):822-31. doi: 10.1164/rccm.200712-1894OC. Epub 2008 Jul 24.
6
Update in cystic fibrosis 2007.
Am J Respir Crit Care Med. 2008 May 15;177(10):1058-61. doi: 10.1164/rccm.200801-069UP.
本文引用的文献
1
Endpoints for clinical trials in young children with cystic fibrosis.
Proc Am Thorac Soc. 2007 Aug 1;4(4):418-30. doi: 10.1513/pats.200703-041BR.
2
Patient-reported outcomes in cystic fibrosis.
Proc Am Thorac Soc. 2007 Aug 1;4(4):378-86. doi: 10.1513/pats.200703-039BR.
3
Advancing outcome measures for the new era of drug development in cystic fibrosis.
Proc Am Thorac Soc. 2007 Aug 1;4(4):370-7. doi: 10.1513/pats.200703-040BR.
4
Monitoring cystic fibrosis lung disease in clinical trials: is it time for a change?
Proc Am Thorac Soc. 2007 Aug 1;4(4):297-8. doi: 10.1513/pats.200611-180HT.
5
Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.
Thorax. 2007 Apr;62(4):360-7. doi: 10.1136/thx.2006.060889.
6
Advances in cystic fibrosis therapies.
Curr Opin Pediatr. 2006 Dec;18(6):604-13. doi: 10.1097/MOP.0b013e3280109b90.
7
Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials.
Am J Respir Crit Care Med. 2006 Oct 1;174(7):787-94. doi: 10.1164/rccm.200509-1377OC. Epub 2006 Jul 13.
8
Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis.
Pediatr Pulmonol. 2006 Jul;41(7):656-65. doi: 10.1002/ppul.20429.
9
Cystic fibrosis pulmonary exacerbations.
J Pediatr. 2006 Feb;148(2):259-64. doi: 10.1016/j.jpeds.2005.10.019.
10
Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules.
Am J Physiol Lung Cell Mol Physiol. 2006 Jun;290(6):L1117-30. doi: 10.1152/ajplung.00169.2005. Epub 2006 Jan 27.
Zotero 插件